ACADIA Pharmaceuticals Inc.

Q3 2024 13F Holders

Symbol
ACAD
CUSIP
004225108
Type
Equity
Class
COM
Num filings
271
Total reported value, excl. options
$2.38 B
Manager Report Date Value ($000) Shares Option Type